Author: Li Shaoguang
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.9, Iss.2, 2005-04, pp. : 329-341
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. :
Idarubicin: Acute lymphoblastic leukaemia: case report
Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. :
Rituximab: Relapse of acute lymphoblastic leukaemia: case report
Reactions Weekly, Vol. 1, Iss. 1177, 2007-01 ,pp. :
Temozolomide: Acute lymphoblastic leukaemia: case report
Reactions Weekly, Vol. 1, Iss. 1371, 2011-01 ,pp. :